Nat Simons Danaher Corp Transaction History

Meritage Group LP

  • $3.77 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$185.1 - $233.13 $33.8 Million - $42.5 Million
182,348 Added 38.55%
655,379 $152 Million
Q3 2023

Nov 13, 2023
SELL
$233.08 - $265.59 $3.19 Million - $3.63 Million
-13,675 Reduced 2.81%
473,031 $117 Million
Q2 2023

Aug 11, 2023
BUY
$224.99 - $256.14 $110 Million - $125 Million
486,706 New
486,706 $117 Million

Others Institutions Holding DHR

# of Institutions
2,491
Shares Held
545M
Call Options Held
7.42M
Put Options Held
4.43M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $148B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track Nat Simons's Portfolio

Track Nat Simons Portfolio

Follow Nat Simons (Meritage Group LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Group LP and Nat Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email